| | 1389264-17-8 Basic information More.. |
| Product Name: | Darapladib-iMpurity | | Synonyms: | Darapladib-iMpurity;N-(2-(Diethylamino)ethyl)-2-((2-((4-fluorobenzyl)thio)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)oxy)-N-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)acetamide;N-(2-Diethylaminoethyl)-2-[[2-[(4-fluorophenyl)methylsulfanyl]-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]oxy]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide;Acetamide, N-[2-(diethylamino)ethyl]-2-[[2-[[(4-fluorophenyl)methyl]thio]-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]oxy]-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]- | | CAS: | 1389264-17-8 | | MF: | C36H38F4N4O2S | | MW: | 666.7711328 | | EINECS: | | | Mol File: | 1389264-17-8.mol |  |
Darapladib-iMpurity manufacturers
- Darapladib-impurity
-
- US $195.00-659.00 / mg
- 2024-11-19
- CAS:1389264-17-8
- Min. Order:
- Purity: 98.04%
- Supply Ability: 10g
|
|
1389264-17-8
Recommend Suppliers |
|